Bartlett & Co’s Takeda Pharmaceutical TAK Stock Holding History

Bartlett & Co’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$296K	Hold	20,781	–	–	﹤0.01%	420
2023 Q3	$321K	Hold	20,781	–	–	0.01%	393
2023 Q2	$333K	Hold	20,781	–	–	0.01%	391
2023 Q1	$342K	Hold	20,781	–	–	0.01%	326
2022 Q4	$324K	Hold	20,781	–	–	0.01%	335
2022 Q3	$270K	Hold	20,781	–	–	0.01%	341
2022 Q2	$299K	Sell	20,781 -151	-0.7%	-$2.15K	0.01%	323
2022 Q1	$300K	Hold	20,932	–	–	0.01%	342
2021 Q4	$285K	Buy	+20,932	New	+$294K	﹤0.01%	358
2021 Q1	–	Sell	-41	Closed	-$1K	–	1166
2020 Q4	$1K	Buy	+41	New	+$719	﹤0.01%	1064
2019 Q2	–	Sell	-116	Closed	-$2K	–	795
2019 Q1	$2K	Buy	+116	New	+$2.33K	﹤0.01%	656

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bartlett & Co's TAK Position: Q4 2023 in Review

Bartlett & Co held its Takeda Pharmaceutical (TAK) position steady in Q4 2023 at 20,781 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #420.

Bartlett & Co first reported a position in TAK in Q1 2019 and has held it in 11 quarters since. The position peaked at $342K in Q1 2023. 306 funds tracked by Wall St. Rank hold TAK as of Q4 2023.

Bartlett & Co held 20,781 shares of Takeda Pharmaceutical worth $296K as of Q4 2023.
Bartlett & Co left its Takeda Pharmaceutical share count unchanged in Q4 2023.
Takeda Pharmaceutical made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #420 holding.
Bartlett & Co first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 11 quarters since.
Bartlett & Co's Takeda Pharmaceutical position peaked at $342K in Q1 2023.
306 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.